BVS Q2 2024 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$151M+10.3% YoY

Gross Profit

$104M68.5% margin

Operating Income

-$31M-20.8% margin

Net Income

-$26M-17.0% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+16.8%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$792M

Total Liabilities

$603M

Stockholders' Equity

$151M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$151M	$137M	+10.3%
Gross Profit	$104M	$89M	+16.3%
Operating Income	-$31M	$7M	-566.3%
Net Income	-$26M	-$4M	-597.7%

Revenue Segments

U.S. Segment

$134M89%

International Segment

$17M11%

Geographic Segments

UNITED STATES

$134M89%

Non-US

$17M11%